China

In this briefing:

1. Best World (BEST SP): BT Article, Franchise and KOL
2. SHIBOR and Rates
3. StubWorld: Wharf Under Pressure As Cooling Measures Bite
4. The Economic and Financial Implications of Closing the Gilded Age for US Technology Companies
5. Global Tech Breakup

1. Best World (BEST SP): BT Article, Franchise and KOL

Best World International (BEST SP) share price has been hammered due to the recent article in Business Times, although the company has addressed them one by one. The annual meeting that recently took place in their office in Singapore shed some light on the seemingly “new but not so new” franchise business model in China. The company also has started to engage Key Opinion Leaders (KOL) aka social media influencers as part of their social selling campaign. 

2. SHIBOR and Rates

There are two important points worth noting. First, China remains an overwhelmingly short term capital market from the money markets to structured deposits to bond duration which remain heavily tilted towards durations under five years. Second, what we are seeing in the money markets accords with the PBOC unofficial policy of trying to keep the headline rate unchanged but nudge down the unofficial rates.

3. StubWorld: Wharf Under Pressure As Cooling Measures Bite

This week in StubWorld …

• Wheelock & (20 HK) is coming up “expensive”, but it’s Wharf Holdings (4 HK) which is under-performing after PRC property sales targets are lowered amid Beijing’s cooling measures.

Preceding my comments on Wheelock and other stubs are the weekly setup/unwind tables for Asia-Pacific Holdcos.

These relationships trade with a minimum liquidity threshold of US$1mn on a 90-day moving average, and a % market capitalisation threshold – the $ value of the holding/opco held, over the parent’s market capitalisation, expressed in percent – of at least 20%.

4. The Economic and Financial Implications of Closing the Gilded Age for US Technology Companies

The technology sector’s influence on the US economy and financial markets over the past two decades has been significant, and largely considered to be beneficial, but these legacies may now be under threat from political and consumer backlashes.

Motivations for regulating large technology companies vary on a cross-border basis, ranging from customer data protection in the European Union (EU) to antitrust issues in the US.

Imposing utility-type regulations on technology companies that limit investment returns will hinder technological innovation, and, consequently, be detrimental to GDP growth for countries with ageing populations.

Digital technology innovation has produced permanent labour-saving investment opportunities in the US that have hollowed out job openings, thereby contributing to a flatter Phillips Curve and populism.

Meanwhile, populism and technological disputes are also evident on a cross-border basis, as testified by the current Sino-US trade standoff and leadership rivalry in 5G technology.

US political intervention after the 2020 Presidential Election could have a major bearing on market structures and capital destruction within the technology sector, particularly if antitrust measures gain bipartisan support.

5. Global Tech Breakup

By Eleanor Olcott, China Policy Analyst at TS Lombard

• Washington’s political drive to block Chinese access to US high-end tech is creating uncertainty in the industry
• The immediate effect is the redirection of Chinese VC money away from the US to Asian and European rivals
• The long-term trend is of  two rival centres of technology production- one focused on Shenzhen, the other on Silicon Valley

In this briefing:

1. SHIBOR and Rates
2. StubWorld: Wharf Under Pressure As Cooling Measures Bite
3. The Economic and Financial Implications of Closing the Gilded Age for US Technology Companies
4. Global Tech Breakup
5. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent

1. SHIBOR and Rates

There are two important points worth noting. First, China remains an overwhelmingly short term capital market from the money markets to structured deposits to bond duration which remain heavily tilted towards durations under five years. Second, what we are seeing in the money markets accords with the PBOC unofficial policy of trying to keep the headline rate unchanged but nudge down the unofficial rates.

2. StubWorld: Wharf Under Pressure As Cooling Measures Bite

This week in StubWorld …

• Wheelock & (20 HK) is coming up “expensive”, but it’s Wharf Holdings (4 HK) which is under-performing after PRC property sales targets are lowered amid Beijing’s cooling measures.

Preceding my comments on Wheelock and other stubs are the weekly setup/unwind tables for Asia-Pacific Holdcos.

These relationships trade with a minimum liquidity threshold of US$1mn on a 90-day moving average, and a % market capitalisation threshold – the $ value of the holding/opco held, over the parent’s market capitalisation, expressed in percent – of at least 20%.

3. The Economic and Financial Implications of Closing the Gilded Age for US Technology Companies

The technology sector’s influence on the US economy and financial markets over the past two decades has been significant, and largely considered to be beneficial, but these legacies may now be under threat from political and consumer backlashes.

Motivations for regulating large technology companies vary on a cross-border basis, ranging from customer data protection in the European Union (EU) to antitrust issues in the US.

Imposing utility-type regulations on technology companies that limit investment returns will hinder technological innovation, and, consequently, be detrimental to GDP growth for countries with ageing populations.

Digital technology innovation has produced permanent labour-saving investment opportunities in the US that have hollowed out job openings, thereby contributing to a flatter Phillips Curve and populism.

Meanwhile, populism and technological disputes are also evident on a cross-border basis, as testified by the current Sino-US trade standoff and leadership rivalry in 5G technology.

US political intervention after the 2020 Presidential Election could have a major bearing on market structures and capital destruction within the technology sector, particularly if antitrust measures gain bipartisan support.

4. Global Tech Breakup

By Eleanor Olcott, China Policy Analyst at TS Lombard

• Washington’s political drive to block Chinese access to US high-end tech is creating uncertainty in the industry
• The immediate effect is the redirection of Chinese VC money away from the US to Asian and European rivals
• The long-term trend is of  two rival centres of technology production- one focused on Shenzhen, the other on Silicon Valley

5. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent

Dongzheng Automotive Finance (2718 HK) is raising up to US$428m in its upcoming IPO. We have covered the background of the company in Dongzheng Auto Finance (东正汽车金融) Pre-IPO Review – Dependent on Dealership Network for Growth. 

In this insight, we will look into the company’s valuation, compare it to listed auto peers, and run the deal through our framework.

In this briefing:

1. StubWorld: Wharf Under Pressure As Cooling Measures Bite
2. The Economic and Financial Implications of Closing the Gilded Age for US Technology Companies
3. Global Tech Breakup
4. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent
5. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)

1. StubWorld: Wharf Under Pressure As Cooling Measures Bite

This week in StubWorld …

• Wheelock & (20 HK) is coming up “expensive”, but it’s Wharf Holdings (4 HK) which is under-performing after PRC property sales targets are lowered amid Beijing’s cooling measures.

Preceding my comments on Wheelock and other stubs are the weekly setup/unwind tables for Asia-Pacific Holdcos.

These relationships trade with a minimum liquidity threshold of US$1mn on a 90-day moving average, and a % market capitalisation threshold – the $ value of the holding/opco held, over the parent’s market capitalisation, expressed in percent – of at least 20%.

2. The Economic and Financial Implications of Closing the Gilded Age for US Technology Companies

The technology sector’s influence on the US economy and financial markets over the past two decades has been significant, and largely considered to be beneficial, but these legacies may now be under threat from political and consumer backlashes.

Motivations for regulating large technology companies vary on a cross-border basis, ranging from customer data protection in the European Union (EU) to antitrust issues in the US.

Imposing utility-type regulations on technology companies that limit investment returns will hinder technological innovation, and, consequently, be detrimental to GDP growth for countries with ageing populations.

Digital technology innovation has produced permanent labour-saving investment opportunities in the US that have hollowed out job openings, thereby contributing to a flatter Phillips Curve and populism.

Meanwhile, populism and technological disputes are also evident on a cross-border basis, as testified by the current Sino-US trade standoff and leadership rivalry in 5G technology.

US political intervention after the 2020 Presidential Election could have a major bearing on market structures and capital destruction within the technology sector, particularly if antitrust measures gain bipartisan support.

3. Global Tech Breakup

By Eleanor Olcott, China Policy Analyst at TS Lombard

• Washington’s political drive to block Chinese access to US high-end tech is creating uncertainty in the industry
• The immediate effect is the redirection of Chinese VC money away from the US to Asian and European rivals
• The long-term trend is of  two rival centres of technology production- one focused on Shenzhen, the other on Silicon Valley

4. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent

Dongzheng Automotive Finance (2718 HK) is raising up to US$428m in its upcoming IPO. We have covered the background of the company in Dongzheng Auto Finance (东正汽车金融) Pre-IPO Review – Dependent on Dealership Network for Growth. 

In this insight, we will look into the company’s valuation, compare it to listed auto peers, and run the deal through our framework.

5. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)

CanSino is a China-based biotechnology company with a focus on vaccine development. In our previous insight (link to Part 1 and Part 2), we have discussed CanSino’s drug pipeline, the competitive landscape, and the valuation. 

As the company is starting pre-marketing, we will provide an updated valuation based on new information obtained from the approved application document. Our base case valuation for CanSino is USD 856 million on a pre-money basis. Majority of the rNPV based SOTP valuation still comes from its meningococcal conjugate vaccine (MCV2 and MCV4). Over the past few months, the company has completed Phase III for MCV4 and submitted NDA (new drug application) for MCV2 candidates.

In this briefing:

1. The Economic and Financial Implications of Closing the Gilded Age for US Technology Companies
2. Global Tech Breakup
3. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent
4. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)
5. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside

1. The Economic and Financial Implications of Closing the Gilded Age for US Technology Companies

The technology sector’s influence on the US economy and financial markets over the past two decades has been significant, and largely considered to be beneficial, but these legacies may now be under threat from political and consumer backlashes.

Motivations for regulating large technology companies vary on a cross-border basis, ranging from customer data protection in the European Union (EU) to antitrust issues in the US.

Imposing utility-type regulations on technology companies that limit investment returns will hinder technological innovation, and, consequently, be detrimental to GDP growth for countries with ageing populations.

Digital technology innovation has produced permanent labour-saving investment opportunities in the US that have hollowed out job openings, thereby contributing to a flatter Phillips Curve and populism.

Meanwhile, populism and technological disputes are also evident on a cross-border basis, as testified by the current Sino-US trade standoff and leadership rivalry in 5G technology.

US political intervention after the 2020 Presidential Election could have a major bearing on market structures and capital destruction within the technology sector, particularly if antitrust measures gain bipartisan support.

2. Global Tech Breakup

By Eleanor Olcott, China Policy Analyst at TS Lombard

• Washington’s political drive to block Chinese access to US high-end tech is creating uncertainty in the industry
• The immediate effect is the redirection of Chinese VC money away from the US to Asian and European rivals
• The long-term trend is of  two rival centres of technology production- one focused on Shenzhen, the other on Silicon Valley

3. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent

Dongzheng Automotive Finance (2718 HK) is raising up to US$428m in its upcoming IPO. We have covered the background of the company in Dongzheng Auto Finance (东正汽车金融) Pre-IPO Review – Dependent on Dealership Network for Growth. 

In this insight, we will look into the company’s valuation, compare it to listed auto peers, and run the deal through our framework.

4. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)

CanSino is a China-based biotechnology company with a focus on vaccine development. In our previous insight (link to Part 1 and Part 2), we have discussed CanSino’s drug pipeline, the competitive landscape, and the valuation. 

As the company is starting pre-marketing, we will provide an updated valuation based on new information obtained from the approved application document. Our base case valuation for CanSino is USD 856 million on a pre-money basis. Majority of the rNPV based SOTP valuation still comes from its meningococcal conjugate vaccine (MCV2 and MCV4). Over the past few months, the company has completed Phase III for MCV4 and submitted NDA (new drug application) for MCV2 candidates.

5. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside

• The stock price has risen 32% after the short seller J Capital slammed it.
• MOMO’s paying user base of live video increased 22% yoy in 3Q18 and 17% yoy in 4Q2018 even though the live show market shrank in 2018.
• We believe MOMO will benefit from small competitors’ bankruptcy.
• The growth rate of the main business revenues stopped declining.
• Our P/E band suggests upside of 80% for MOMO’s stock price.

In this briefing:

1. Global Tech Breakup
2. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent
3. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)
4. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside
5. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability

1. Global Tech Breakup

By Eleanor Olcott, China Policy Analyst at TS Lombard

• Washington’s political drive to block Chinese access to US high-end tech is creating uncertainty in the industry
• The immediate effect is the redirection of Chinese VC money away from the US to Asian and European rivals
• The long-term trend is of  two rival centres of technology production- one focused on Shenzhen, the other on Silicon Valley

2. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent

Dongzheng Automotive Finance (2718 HK) is raising up to US$428m in its upcoming IPO. We have covered the background of the company in Dongzheng Auto Finance (东正汽车金融) Pre-IPO Review – Dependent on Dealership Network for Growth. 

In this insight, we will look into the company’s valuation, compare it to listed auto peers, and run the deal through our framework.

3. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)

CanSino is a China-based biotechnology company with a focus on vaccine development. In our previous insight (link to Part 1 and Part 2), we have discussed CanSino’s drug pipeline, the competitive landscape, and the valuation. 

As the company is starting pre-marketing, we will provide an updated valuation based on new information obtained from the approved application document. Our base case valuation for CanSino is USD 856 million on a pre-money basis. Majority of the rNPV based SOTP valuation still comes from its meningococcal conjugate vaccine (MCV2 and MCV4). Over the past few months, the company has completed Phase III for MCV4 and submitted NDA (new drug application) for MCV2 candidates.

4. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside

• The stock price has risen 32% after the short seller J Capital slammed it.
• MOMO’s paying user base of live video increased 22% yoy in 3Q18 and 17% yoy in 4Q2018 even though the live show market shrank in 2018.
• We believe MOMO will benefit from small competitors’ bankruptcy.
• The growth rate of the main business revenues stopped declining.
• Our P/E band suggests upside of 80% for MOMO’s stock price.

5. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability

• Conference call with Meituan Dianping (3690 HK) reveals that ballooning losses from new initiatives (incl. one-off expenses) largely contributed to record quarterly EBIT losses in 4Q18.
• Importantly, this masks Meituan Core’s (combined food delivery and in-store, hotel & travel divisions) continued progress toward profitability.
• Management is bullish on every division’s outlook in 2019, particularly guiding for 1) balanced growth and profitability strategy for food delivery and 2) disciplined investments in new initiatives.
• Meituan attractively trades at 2.9x 2019E P/S, only around half of peers’ valuation (5.5x).  

In this briefing:

1. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent
2. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)
3. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside
4. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability
5. Ruhnn IPO Preview: Hard to Stay Red-Hot for Long

1. Dongzheng Auto Finance (东正汽车金融) IPO Review – Better off Buying the Parent

Dongzheng Automotive Finance (2718 HK) is raising up to US$428m in its upcoming IPO. We have covered the background of the company in Dongzheng Auto Finance (东正汽车金融) Pre-IPO Review – Dependent on Dealership Network for Growth. 

In this insight, we will look into the company’s valuation, compare it to listed auto peers, and run the deal through our framework.

2. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)

CanSino is a China-based biotechnology company with a focus on vaccine development. In our previous insight (link to Part 1 and Part 2), we have discussed CanSino’s drug pipeline, the competitive landscape, and the valuation. 

As the company is starting pre-marketing, we will provide an updated valuation based on new information obtained from the approved application document. Our base case valuation for CanSino is USD 856 million on a pre-money basis. Majority of the rNPV based SOTP valuation still comes from its meningococcal conjugate vaccine (MCV2 and MCV4). Over the past few months, the company has completed Phase III for MCV4 and submitted NDA (new drug application) for MCV2 candidates.

3. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside

• The stock price has risen 32% after the short seller J Capital slammed it.
• MOMO’s paying user base of live video increased 22% yoy in 3Q18 and 17% yoy in 4Q2018 even though the live show market shrank in 2018.
• We believe MOMO will benefit from small competitors’ bankruptcy.
• The growth rate of the main business revenues stopped declining.
• Our P/E band suggests upside of 80% for MOMO’s stock price.

4. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability

• Conference call with Meituan Dianping (3690 HK) reveals that ballooning losses from new initiatives (incl. one-off expenses) largely contributed to record quarterly EBIT losses in 4Q18.
• Importantly, this masks Meituan Core’s (combined food delivery and in-store, hotel & travel divisions) continued progress toward profitability.
• Management is bullish on every division’s outlook in 2019, particularly guiding for 1) balanced growth and profitability strategy for food delivery and 2) disciplined investments in new initiatives.
• Meituan attractively trades at 2.9x 2019E P/S, only around half of peers’ valuation (5.5x).  

5. Ruhnn IPO Preview: Hard to Stay Red-Hot for Long

Ruhnn Holding Ltd (RUHN US) is an e-commerce platform which drives sales through KOLs (key opinion leaders). Ruhnn is the largest internet KOL facilitator in China as measured by revenue, the number of online stores and GMV in 2018 according to Frost & Sullivan. Ruhnn is backed by Alibaba Group Holding (BABA US), an 8.6% shareholder, and is seeking to raise $200 million through a Nasdaq IPO.

In this briefing:

1. Trade During Lunar New Year
2. Why China’s Stimulus Will Disappoint
3. Dongzheng Auto Finance (东正汽车金融) Pre-IPO Review – Dependent on Dealership Network for Growth
4. Up Fintech (Tiger Brokers) IPO Quick Take – It’s Not like Futu, Won’t Perform like It Either
5. Meituan Dianping 4Q2018 Quick Read: Monetization Rate and Margins Disappointed

1. Trade During Lunar New Year

An underlying issue regarding February data is just how pressurized it is. Between cross armed speculations about trade talk negotiations and the biggest Chinese holiday, it should come as no surprises that February data is underwhelming. Chinese markets are still grappling with a way forward in the trade talk quagmire, but February numbers are in many ways seasonal, due to the holiday snapshot it encompasses.

2. Why China’s Stimulus Will Disappoint

By Lawrence Brainard, Chief Emerging Market Economist at TS Lombard

• In a Chinese version of QE the PBoC is flooding markets with liquidity
• Commercial banks will be slow to use it to boost lending to SMEs

3. Dongzheng Auto Finance (东正汽车金融) Pre-IPO Review – Dependent on Dealership Network for Growth

Dongzheng Automotive Finance (2718 HK) is looking to raise approximately US$300 – 500m in its upcoming IPO. 

DAF is a fast growing auto finance company which acquires customers through a network of dealership around China. Its net interest income grew by 66% CAGR from FY2016 to FY2018 while net fees/comms income and profit grew by 39.6% and 61% CAGR over the same period.

However, most of its growth originated from ZhengTong dealers and joint promotion arrangement. Excluding loans from joint promotion arrangement, gross outstanding loan had only grown by 12% CAGR.

In this insight, we will look at the company’s business, analyze the competitive landscape, provide thoughts on valuation, and some questions for management.

4. Up Fintech (Tiger Brokers) IPO Quick Take – It’s Not like Futu, Won’t Perform like It Either

Up Fintech (TIGR US) plans to raise up to US$91m in its US listing. The company counts Xiaomi Corp (1810 HK) and Interactive Brokers Group, Inc (IBKR US) as its main investors.

In my earlier insights, I commented about Tiger’s reliance on IBKR and compared its operations with Futu Holdings Ltd (FHL US):

• Up Fintech (Tiger Brokers) Pre-IPO Quick Note – Much Too Reliant on IBKR
• Futu Holdings IPO Quick Note – Comparison with Tiger Brokers – Same Market, Different Economics

In this insight, I’ll run the deal through our framework and comment on valuations.

5. Meituan Dianping 4Q2018 Quick Read: Monetization Rate and Margins Disappointed

Meituan Dianping reported 4Q2018 numbers last night. As we covered the company’s IPO and lock-up expiry, we took a close look the company 4Q2018 results and listened in the conference call. While we are encouraged by the company’s strong transaction volume and revenue growth in 4Q2018, we are less bullish given the deceleration of monetization growth. We also note that the company trimmed down the details of reporting, in particular, the operation of its New Initiative segment and hence results were less transparent. 

In this briefing:

1. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)
2. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside
3. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability
4. Ruhnn IPO Preview: Hard to Stay Red-Hot for Long
5. Raw Materials and Retail Pricing

1. CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)

CanSino is a China-based biotechnology company with a focus on vaccine development. In our previous insight (link to Part 1 and Part 2), we have discussed CanSino’s drug pipeline, the competitive landscape, and the valuation. 

As the company is starting pre-marketing, we will provide an updated valuation based on new information obtained from the approved application document. Our base case valuation for CanSino is USD 856 million on a pre-money basis. Majority of the rNPV based SOTP valuation still comes from its meningococcal conjugate vaccine (MCV2 and MCV4). Over the past few months, the company has completed Phase III for MCV4 and submitted NDA (new drug application) for MCV2 candidates.

2. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside

• The stock price has risen 32% after the short seller J Capital slammed it.
• MOMO’s paying user base of live video increased 22% yoy in 3Q18 and 17% yoy in 4Q2018 even though the live show market shrank in 2018.
• We believe MOMO will benefit from small competitors’ bankruptcy.
• The growth rate of the main business revenues stopped declining.
• Our P/E band suggests upside of 80% for MOMO’s stock price.

3. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability

• Conference call with Meituan Dianping (3690 HK) reveals that ballooning losses from new initiatives (incl. one-off expenses) largely contributed to record quarterly EBIT losses in 4Q18.
• Importantly, this masks Meituan Core’s (combined food delivery and in-store, hotel & travel divisions) continued progress toward profitability.
• Management is bullish on every division’s outlook in 2019, particularly guiding for 1) balanced growth and profitability strategy for food delivery and 2) disciplined investments in new initiatives.
• Meituan attractively trades at 2.9x 2019E P/S, only around half of peers’ valuation (5.5x).  

4. Ruhnn IPO Preview: Hard to Stay Red-Hot for Long

Ruhnn Holding Ltd (RUHN US) is an e-commerce platform which drives sales through KOLs (key opinion leaders). Ruhnn is the largest internet KOL facilitator in China as measured by revenue, the number of online stores and GMV in 2018 according to Frost & Sullivan. Ruhnn is backed by Alibaba Group Holding (BABA US), an 8.6% shareholder, and is seeking to raise $200 million through a Nasdaq IPO.

5. Raw Materials and Retail Pricing

What the pricing data seems to imply is that consumer prices remain relatively steady but trending slightly downward, likely from weakness in household consumption that mirrors the broader economic trends. Corporate and producer sector data is driven by weakness in commodities and raw materials that seem hard pressed to accelerate in 2019 given the high base effect from 2018. 

In this briefing:

1. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside
2. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability
3. Ruhnn IPO Preview: Hard to Stay Red-Hot for Long
4. Raw Materials and Retail Pricing
5. Trade During Lunar New Year

1. Momo (MOMO): Paying Users Up 17%, Benefiting from Bankrupt Competitors, 80% Upside

• The stock price has risen 32% after the short seller J Capital slammed it.
• MOMO’s paying user base of live video increased 22% yoy in 3Q18 and 17% yoy in 4Q2018 even though the live show market shrank in 2018.
• We believe MOMO will benefit from small competitors’ bankruptcy.
• The growth rate of the main business revenues stopped declining.
• Our P/E band suggests upside of 80% for MOMO’s stock price.

2. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability

• Conference call with Meituan Dianping (3690 HK) reveals that ballooning losses from new initiatives (incl. one-off expenses) largely contributed to record quarterly EBIT losses in 4Q18.
• Importantly, this masks Meituan Core’s (combined food delivery and in-store, hotel & travel divisions) continued progress toward profitability.
• Management is bullish on every division’s outlook in 2019, particularly guiding for 1) balanced growth and profitability strategy for food delivery and 2) disciplined investments in new initiatives.
• Meituan attractively trades at 2.9x 2019E P/S, only around half of peers’ valuation (5.5x).  

3. Ruhnn IPO Preview: Hard to Stay Red-Hot for Long

Ruhnn Holding Ltd (RUHN US) is an e-commerce platform which drives sales through KOLs (key opinion leaders). Ruhnn is the largest internet KOL facilitator in China as measured by revenue, the number of online stores and GMV in 2018 according to Frost & Sullivan. Ruhnn is backed by Alibaba Group Holding (BABA US), an 8.6% shareholder, and is seeking to raise $200 million through a Nasdaq IPO.

4. Raw Materials and Retail Pricing

What the pricing data seems to imply is that consumer prices remain relatively steady but trending slightly downward, likely from weakness in household consumption that mirrors the broader economic trends. Corporate and producer sector data is driven by weakness in commodities and raw materials that seem hard pressed to accelerate in 2019 given the high base effect from 2018. 

5. Trade During Lunar New Year

An underlying issue regarding February data is just how pressurized it is. Between cross armed speculations about trade talk negotiations and the biggest Chinese holiday, it should come as no surprises that February data is underwhelming. Chinese markets are still grappling with a way forward in the trade talk quagmire, but February numbers are in many ways seasonal, due to the holiday snapshot it encompasses.

In this briefing:

1. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability
2. Ruhnn IPO Preview: Hard to Stay Red-Hot for Long
3. Raw Materials and Retail Pricing
4. Trade During Lunar New Year
5. Why China’s Stimulus Will Disappoint

1. Meituan Dianping: Time to Bail? Relax, Core Business Progressing Toward Profitability

• Conference call with Meituan Dianping (3690 HK) reveals that ballooning losses from new initiatives (incl. one-off expenses) largely contributed to record quarterly EBIT losses in 4Q18.
• Importantly, this masks Meituan Core’s (combined food delivery and in-store, hotel & travel divisions) continued progress toward profitability.
• Management is bullish on every division’s outlook in 2019, particularly guiding for 1) balanced growth and profitability strategy for food delivery and 2) disciplined investments in new initiatives.
• Meituan attractively trades at 2.9x 2019E P/S, only around half of peers’ valuation (5.5x).  

2. Ruhnn IPO Preview: Hard to Stay Red-Hot for Long

Ruhnn Holding Ltd (RUHN US) is an e-commerce platform which drives sales through KOLs (key opinion leaders). Ruhnn is the largest internet KOL facilitator in China as measured by revenue, the number of online stores and GMV in 2018 according to Frost & Sullivan. Ruhnn is backed by Alibaba Group Holding (BABA US), an 8.6% shareholder, and is seeking to raise $200 million through a Nasdaq IPO.

3. Raw Materials and Retail Pricing

What the pricing data seems to imply is that consumer prices remain relatively steady but trending slightly downward, likely from weakness in household consumption that mirrors the broader economic trends. Corporate and producer sector data is driven by weakness in commodities and raw materials that seem hard pressed to accelerate in 2019 given the high base effect from 2018. 

4. Trade During Lunar New Year

An underlying issue regarding February data is just how pressurized it is. Between cross armed speculations about trade talk negotiations and the biggest Chinese holiday, it should come as no surprises that February data is underwhelming. Chinese markets are still grappling with a way forward in the trade talk quagmire, but February numbers are in many ways seasonal, due to the holiday snapshot it encompasses.

5. Why China’s Stimulus Will Disappoint

By Lawrence Brainard, Chief Emerging Market Economist at TS Lombard

• In a Chinese version of QE the PBoC is flooding markets with liquidity
• Commercial banks will be slow to use it to boost lending to SMEs